|Articles|July 11, 2018
Synteract Acquires Dermatology Specialist CRO Cu-Tech
Advertisement
Synteract, a CRO providing full-service Phase I-IV clinical trials, has acquired Cu-Tech, a dermatology specialist CRO. With this acquirement, Synteract has created a dedicated center of dermatology development.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
2
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
3
Accelerate Clinical Trials with AI-Enhanced Financial Management
4
SCOPE Summit 2026 Keynote Fireside Chat: Aligning Purpose, Innovation, and Operational Excellence in Clinical Development
5